Intended use:

For in vitro diagnostic use. The RIDASCREEN® VDZ Monitoring is an enzyme linked immunosorbent assay intended for the quantitative determination of vedolizumab (VDZ, Entyvio®, anti- integrin α4β7) in human serum and plasma.

Product information

Vedolizumab (VDZ, Entyvio®) is approved for the treatment of patients with moderate to severe Crohn’s disease and ulcerative colitis in whom conventional therapy or anti-TNFα therapies were ineffective or not tolerated. It is a gut-specific, humanized monoclonal antibody targeting the α4β7-integrin protein, which is involved in the migration of lymphocytes to the gut. Similar as to anti-TNFα drugs, measurement of vedolizumab drug concentrations supports a personalized dosing strategy in patients treated with vedolizumab.

The RIDASCREEN® VDZ Monitoring and our other TDM assays are vital to personalize treatment of patients with Crohn’s disease and ulcerative colitis and better achieve therapeutic targets.

Key features

  • CE-marked versions of the ELISA tests of KU Leuven
  • Highly specific antibodies
  • Ready to use reagents
  • Validated for use on automated ELISA systems, e.g. the Dynex DSX®
Art. No. G09045
Test format Microtiter plate with 96 wells (12 strips with 8 removable wells each)
Incubation time 1 h 40 min
Spanish (English) (German) (French) (Italian) (Spanish)
Similar Products
For in-vitro diagnostics. Stool collection tubes (without buffer) for the stool sample taking and extraction in laboratories.
RIDASCREEN® Zika Virus IgG capture, IgM µ-capture
RIDASCREEN® Zika Virus IgG ...
For in vitro diagnostic use. The RIDASCREEN® Zika Virus tests are enzyme immunoassays for the qualitative detection of IgG or IgM antibodies to the...
RIDASCREEN® Malaria Ab-Screening
RIDASCREEN® Malaria Ab-Scre...
For in vitro diagnostic use. The RIDASCREEN® Malaria Ab-Screening test is an enzyme immunoassay for the qualitative detection of IgG and IgM antibo...

Start typing and press Enter to search